US Ecology Inc (ECOL) investors sentiment decreased to 1.45 in Q1 2018. It’s down -0.18, from 1.63 in 2017Q4. The ratio turned negative, as 64 investment managers opened new or increased positions, while 44 trimmed and sold stakes in US Ecology Inc. The investment managers in our database now possess: 18.20 million shares, up from 17.78 million shares in 2017Q4. Also, the number of investment managers holding US Ecology Inc in top ten positions was flat from 0 to 0 for the same number . Sold All: 8 Reduced: 36 Increased: 44 New Position: 20.
Boltwood Capital Management decreased Pfizer (PFE) stake by 74.92% reported in 2018Q1 SEC filing. Boltwood Capital Management sold 230,315 shares as Pfizer (PFE)’s stock declined 3.80%. The Boltwood Capital Management holds 77,096 shares with $2.74 million value, down from 307,411 last quarter. Pfizer now has $208.83B valuation. The stock increased 0.06% or $0.02 during the last trading session, reaching $35.7. About 26.74 million shares traded or 24.31% up from the average. Pfizer Inc. (NYSE:PFE) has risen 10.95% since May 30, 2017 and is uptrending. It has underperformed by 1.62% the S&P500.
Since January 1, 0001, it had 0 insider buys, and 6 sales for $2.53 million activity.
More notable recent US Ecology, Inc. (NASDAQ:ECOL) news were published by: Globenewswire.com which released: “US Ecology Board Reaffirms Capital Allocation Strategy” on May 29, 2018, also Seekingalpha.com with their article: “US Ecology’s (ECOL) CEO Jeff Feeler on Q1 2018 Results – Earnings Call Transcript” published on May 04, 2018, Nasdaq.com published: “Report: Developing Opportunities within US Ecology, Universal Health Realty Income Trust, Accelerate Diagnostics …” on May 04, 2018. More interesting news about US Ecology, Inc. (NASDAQ:ECOL) were released by: Fool.com and their article: “US Ecology’s Momentum Continues” published on May 04, 2018 as well as Seekingalpha.com‘s news article titled: “Bright Lights On Capitalist Woodstock, Tech Developers And Sports Betting” with publication date: May 05, 2018.
US Ecology, Inc., through its subsidiaries, provides environmental services to commercial and government entities in the United States, Canada, and Mexico. The company has market cap of $1.32 billion. It operates in two divisions, Environmental Services; and Field & Industrial Services. It has a 24.68 P/E ratio. The Environmental Services segment offers hazardous material management services, including transportation, recycling, treatment, and disposal of hazardous and non-hazardous waste at its landfill, wastewater, and other treatment facilities.
Analysts await US Ecology, Inc. (NASDAQ:ECOL) to report earnings on July, 26. They expect $0.53 earnings per share, up 39.47% or $0.15 from last year’s $0.38 per share. ECOL’s profit will be $11.64 million for 28.28 P/E if the $0.53 EPS becomes a reality. After $0.36 actual earnings per share reported by US Ecology, Inc. for the previous quarter, Wall Street now forecasts 47.22% EPS growth.
The stock increased 1.18% or $0.7 during the last trading session, reaching $59.95. About 39,472 shares traded. US Ecology, Inc. (ECOL) has risen 18.15% since May 30, 2017 and is uptrending. It has outperformed by 5.58% the S&P500.
Fenimore Asset Management Inc holds 0.94% of its portfolio in US Ecology, Inc. for 456,452 shares. Silvercrest Asset Management Group Llc owns 1.60 million shares or 0.83% of their US portfolio. Moreover, Redmond Asset Management Llc has 0.49% invested in the company for 22,251 shares. The Georgia-based Chatham Capital Group Inc. has invested 0.4% in the stock. Naples Global Advisors Llc, a Florida-based fund reported 19,950 shares.
Among 22 analysts covering Pfizer (NYSE:PFE), 9 have Buy rating, 1 Sell and 12 Hold. Therefore 41% are positive. Pfizer has $54.0 highest and $33.0 lowest target. $39.90’s average target is 11.76% above currents $35.7 stock price. Pfizer had 79 analyst reports since July 29, 2015 according to SRatingsIntel. Argus Research maintained the stock with “Buy” rating in Wednesday, July 29 report. The firm has “Neutral” rating by Societe Generale given on Friday, March 24. On Thursday, October 19 the stock rating was maintained by BMO Capital Markets with “Outperform”. The rating was maintained by Jefferies with “Hold” on Monday, February 26. BMO Capital Markets maintained the stock with “Hold” rating in Monday, June 12 report. Jefferies downgraded the shares of PFE in report on Thursday, October 13 to “Hold” rating. The stock has “Outperform” rating by BMO Capital Markets on Wednesday, May 2. The firm has “Hold” rating given on Tuesday, January 16 by Jefferies. On Tuesday, September 13 the stock rating was maintained by Jefferies with “Buy”. The firm has “Buy” rating given on Monday, June 20 by Jefferies.
Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It turned negative, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. Accredited Investors Incorporated owns 24,585 shares. Stonebridge Cap Advsrs Ltd Liability Co has invested 0.19% in Pfizer Inc. (NYSE:PFE). Sentry Investments Corporation invested in 1.51 million shares. Thompson Siegel Walmsley Limited Co stated it has 0.17% in Pfizer Inc. (NYSE:PFE). Clarivest Asset Mngmt Limited Liability Corporation invested in 0% or 254 shares. 26,000 were accumulated by New Jersey Better Educational Savings Trust. First American Financial Bank reported 0.49% in Pfizer Inc. (NYSE:PFE). Amer Assets Invest Management Limited Liability Com has 57,000 shares. Barnett & invested in 716 shares. Oklahoma-based Trust Of Oklahoma has invested 0% in Pfizer Inc. (NYSE:PFE). The Illinois-based Great Lakes Advsr Lc has invested 0.02% in Pfizer Inc. (NYSE:PFE). Strategy Asset Managers Ltd Co holds 304,767 shares. Valley Advisers owns 75,970 shares. Intrust Savings Bank Na holds 0.66% or 64,417 shares. Stratos Wealth Partners Limited invested in 173,901 shares.
Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on August, 7. They expect $0.75 EPS, up 11.94% or $0.08 from last year’s $0.67 per share. PFE’s profit will be $4.39 billion for 11.90 P/E if the $0.75 EPS becomes a reality. After $0.77 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts -2.60% negative EPS growth.
The post Boltwood Capital Management Has Cut Its Pfizer (PFE) Holding; US Ecology (ECOL)’s Sentiment Is 1.45 appeared first on Stock Market News | HillCountryTimes | Get it Today.
from
https://www.hillcountrytimes.com/2018/05/30/boltwood-capital-management-has-cut-its-pfizer-pfe-holding-us-ecology-ecols-sentiment-is-1-45/
No comments:
Post a Comment